Roberto Fiocca

Policlinico San Matteo Fondazione — Italy

Medicine · Health Sciences

65h-index14.2kcitations372works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Helicobacter pylori-related gastroenterology studies(130), Eosinophilic Esophagitis(82), Gastroesophageal reflux and treatments(74), Gastric Cancer Management and Outcomes(73), Genetic factors in colorectal cancer(42)

Publications371 total

Vasculopathy as a Mechanical Barrier to Cancer Spread: Clinical Evidence and a Rheology-Based Model in Lung Cancer
2026Open Access
Fibroblast‐driven MMP‐9/TIMP‐1 imbalance in bronchoalveolar lavage reflects fibrotic progression in interstitial lung disease
European Journal of Clinical Investigation·2025
Pre-Surgical Endoscopic Biopsies Are Representative of Esophageal and Esophago-Gastric Junction Adenocarcinoma Histologic Classes and Survival Risk
Cancers·2024· 1 citedOpen Access
miRNA–221 and miRNA–483–3p Dysregulation in Esophageal Adenocarcinoma
Cancers·2024· 3 citedOpen Access
miRNA-221 and miRNA-483-3p Dysregulation Correlated with Poor Survival in Esophageal Adenocarcinoma
Preprints.org·2023· 1 citedOpen Access
Detection of a Novel MSI2-C17orf64 Transcript in a Patient with Aggressive Adenocarcinoma of the Gastroesophageal Junction: A Case Report
Genes·2023· 2 citedOpen Access
Data from Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer
2023Open Access
Data from Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer
2023Open Access
Supplementary Figure2 from Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer
2023Open Access
Supplementary table 1 from Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer
2023Open Access
Supplementary table 1 from Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer
2023Open Access
Supplementary Figure1 from Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer
2023Open Access
Supplementary Figure1 from Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer
2023Open Access
Supplementary figure legend from Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer
2023Open Access
Supplementary figure legend from Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer
2023Open Access
Supplementary Figure2 from Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer
2023Open Access
Correlations between Molecular Alterations, Histopathological Characteristics, and Poor Prognosis in Esophageal Adenocarcinoma
Cancers·2023· 8 citedOpen Access
490. CORRELATION BETWEEN HISTOLOGICAL AND MOLECULAR ALTERATIONS WITH POOR SURVIVAL IN ESOPHAGEAL ADENOCARCINOMA
Diseases of the Esophagus·2022
456. THE PROGNOSTIC IMPACT OF TUMOR BUDDING IN ESOPHAGEAL ADENOCARCINOMA
Diseases of the Esophagus·2022
HLA-G as a prognostic marker in stage II/III colorectal cancer: not quite there yet
Histochemistry and Cell Biology·2022· 13 citedOpen Access
page 1 of 19Next →

Frequent Co-authors

Enrico Solcia(19), Luca Mastracci(10), Laura Villani(10), Ombretta Luinetti(9), Federica Grillo(6), Tore Lind(5), Matteo Cornaggia(5), Mauro Delorenzi(4), Eric Van Cutsem(4), Fred T. Bosman(4), Stephen Attwood(4), Stefan Eklund(4), Christian Ell(4), Lars Lundell(4), Carlo Capella(4), C. Capella(4), E. Trespi(4), Sabine Tejpar(3), Dirk Klingbiel(3), Roberto Labianca(3)